產(chǎn)品詳情
簡(jiǎn)單介紹：
ATCC 27853 銅綠假單胞菌大腸埃希菌現(xiàn)貨供應(yīng) ATCC 菌種 上海復(fù)祥生物公司現(xiàn)貨供應(yīng)美國(guó)典型培養(yǎng)物保藏中心(ATCC)菌種。所謂"踏破鐵鞋無覓處.得來全不費(fèi)工夫!"
詳情介紹：
ATCC 27853 銅綠假單胞菌
ATCC® Number: 27853?
Preceptrol® Culture
Organism: Pseudomonas aeruginosa (Schroeter) Migula
Designations: Boston 41501
Isolation: blood culture
Depositor: AA Medeiros
Biosafety Level: 2
Shipped: freeze-dried
Growth Conditions: ATCC medium18: Trypticase soy agar
Temperature: 37.0°C
Atmosphere: Aerobic
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Cross References: Nucleotide (GenBank) : AB037545 Pseudomonas aeruginosa gene for 16S ribosomal RNA, strain:ATCC 27853.
Nucleotide (GenBank) : AF094719 Pseudomonas aeruginosa strain ATCC 27853 16S ribosomal RNA gene, partial sequence.
Nucleotide (GenBank) : M63957 Pseudomonas aeruginosa heat shock protein (groES and groEL) genes, complete cds.
Nucleotide (GenBank) : U07832 Pseudomonas aeruginosa helicase I (helA) gene, partial cds.
Nucleotide (GenBank) : U64101 Pseudomonas aeruginosa heat shock protein (groesEL) gene, partial cds.
Nucleotide (GenBank) : U67855 Pseudomonas aeruginosa UDP-3-O-acyl-GlcNAc deacetylase (lpxC) gene, complete cds.
Nucleotide (GenBank) : X65933 P. aeruginosa pa-1L gene for PA-I galactophilic lectin.
Comments: Comment: Incorrectly cited in previous editions of this catalog as identical to NCTC 10662.
effect of salt concentration on gentamicin susceptibility [10999]
This strain is a quality control strain for the Etest Metallo Beta-Lactamase (MBL) strip. [16173367]
Applications: control strain [21528] [21531]
evaluation of Mueller-Hinton agar [21524] [21585]
media testing [21529] [92284] [92390] [92429] [92845]
quality control strain [92112] [92116] [92127] [92135] [92136] [92137] [92150] [92159] [92160] [92169] [92170] [92172] [92173] [92177] [92179]
susceptibility disc testing [21523] [92224] [92355]
susceptibility testing [21525] [21533] [90283] [92219] [92353] [92422] [92423] [92424] [92425] [92788]
testing [92374]
quality control strain for Abbott, API, Autobac, BBL, bioMerieux Vitek, Micro-Media, MicroScan [Reg TM], Roche Diagnostics, and Sensititre products
Related Products: purified DNA: 27853D-5
References: 10999: Medeiros AA, et al. Effect of salt concentration on the apparent in-vitro susceptibility of Pseudomonas and other gram-negative bacilli to gentamicin. J. Infect. Dis. 124: 59-66, 1971. PubMed: 5001630
21523: CLSI Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard - 9th Edition. Wayne, PA:Clinical and Laboratory Standards Institute;CLSI M2-A9.
21524: CLSI Protocols for Evaluating Dehydrated Mueller-Hinton Agar; Approved Standard. Wayne, PA:Clinical and Laboratory Standards Institute;CLSI M6-A.
21525: CLSI Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard - 7th Edition. Wayne, PA:Clinical and Laboratory Standards Institute;CLSI M7-A7.
21528: CLSI Methodology for the Serum Bactericidal test: Approved Guideline. Wayne, PA:Clinical and Laboratory Standards Institute;CLSI M21-A.
21529: CLSI Quality Control for Commercially Prepared Microbiological Culture Media; Approved Standard - 3rd Edition. Wayne, PA:Clinical and Laboratory Standards Institute;CLSI M22-A3.
21531: CLSI Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline. Wayne, PA:Clinical and Laboratory Standards Institute;CLSI M26-A.
21533: CLSI Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard - 2nd Edition. Wayne, PA:Clinical and Laboratory Standards Institute;CLSI M31-A2.
21585: US General Services Administration Mueller Hinton Medium, dehydrated. Washington, DC:US General Services Administration;Commercial Item Description A-A-50904A, 1986
28078: Hyland SA, et al. Cloning, expression, and purification of UDP-3-O-acyl-GlcNAc deacetylase from Pseudomonas aeruginosa: a metalloamidase of the lipid A biosynthesis pathway. J. Bacteriol. 179: 2029-2037, 1997. PubMed: 9068651
32528: O'Callaghan RJ, et al. The role of an uncharacterized exoprotein, protease IV, in corneal virulence. Invest. Ophthalmol. Vis. Sci. 37: 534-543, 1996. PubMed: 8595953
90283: CLSI Performance Standards for Antimicrobial Susceptibility Testing; Sixteenth Informational Supplement. Wayne, PA:Clinical and Laboratory Standards Institute;CLSI M100-S17, 2007
92112: API 20 NE. bioMerieux
ATCC® Number: 27853?
Preceptrol® Culture
Organism: Pseudomonas aeruginosa (Schroeter) Migula
Designations: Boston 41501
Isolation: blood culture
Depositor: AA Medeiros
Biosafety Level: 2
Shipped: freeze-dried
Growth Conditions: ATCC medium18: Trypticase soy agar
Temperature: 37.0°C
Atmosphere: Aerobic
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Cross References: Nucleotide (GenBank) : AB037545 Pseudomonas aeruginosa gene for 16S ribosomal RNA, strain:ATCC 27853.
Nucleotide (GenBank) : AF094719 Pseudomonas aeruginosa strain ATCC 27853 16S ribosomal RNA gene, partial sequence.
Nucleotide (GenBank) : M63957 Pseudomonas aeruginosa heat shock protein (groES and groEL) genes, complete cds.
Nucleotide (GenBank) : U07832 Pseudomonas aeruginosa helicase I (helA) gene, partial cds.
Nucleotide (GenBank) : U64101 Pseudomonas aeruginosa heat shock protein (groesEL) gene, partial cds.
Nucleotide (GenBank) : U67855 Pseudomonas aeruginosa UDP-3-O-acyl-GlcNAc deacetylase (lpxC) gene, complete cds.
Nucleotide (GenBank) : X65933 P. aeruginosa pa-1L gene for PA-I galactophilic lectin.
Comments: Comment: Incorrectly cited in previous editions of this catalog as identical to NCTC 10662.
effect of salt concentration on gentamicin susceptibility [10999]
This strain is a quality control strain for the Etest Metallo Beta-Lactamase (MBL) strip. [16173367]
Applications: control strain [21528] [21531]
evaluation of Mueller-Hinton agar [21524] [21585]
media testing [21529] [92284] [92390] [92429] [92845]
quality control strain [92112] [92116] [92127] [92135] [92136] [92137] [92150] [92159] [92160] [92169] [92170] [92172] [92173] [92177] [92179]
susceptibility disc testing [21523] [92224] [92355]
susceptibility testing [21525] [21533] [90283] [92219] [92353] [92422] [92423] [92424] [92425] [92788]
testing [92374]
quality control strain for Abbott, API, Autobac, BBL, bioMerieux Vitek, Micro-Media, MicroScan [Reg TM], Roche Diagnostics, and Sensititre products
Related Products: purified DNA: 27853D-5
References: 10999: Medeiros AA, et al. Effect of salt concentration on the apparent in-vitro susceptibility of Pseudomonas and other gram-negative bacilli to gentamicin. J. Infect. Dis. 124: 59-66, 1971. PubMed: 5001630
21523: CLSI Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard - 9th Edition. Wayne, PA:Clinical and Laboratory Standards Institute;CLSI M2-A9.
21524: CLSI Protocols for Evaluating Dehydrated Mueller-Hinton Agar; Approved Standard. Wayne, PA:Clinical and Laboratory Standards Institute;CLSI M6-A.
21525: CLSI Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard - 7th Edition. Wayne, PA:Clinical and Laboratory Standards Institute;CLSI M7-A7.
21528: CLSI Methodology for the Serum Bactericidal test: Approved Guideline. Wayne, PA:Clinical and Laboratory Standards Institute;CLSI M21-A.
21529: CLSI Quality Control for Commercially Prepared Microbiological Culture Media; Approved Standard - 3rd Edition. Wayne, PA:Clinical and Laboratory Standards Institute;CLSI M22-A3.
21531: CLSI Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline. Wayne, PA:Clinical and Laboratory Standards Institute;CLSI M26-A.
21533: CLSI Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard - 2nd Edition. Wayne, PA:Clinical and Laboratory Standards Institute;CLSI M31-A2.
21585: US General Services Administration Mueller Hinton Medium, dehydrated. Washington, DC:US General Services Administration;Commercial Item Description A-A-50904A, 1986
28078: Hyland SA, et al. Cloning, expression, and purification of UDP-3-O-acyl-GlcNAc deacetylase from Pseudomonas aeruginosa: a metalloamidase of the lipid A biosynthesis pathway. J. Bacteriol. 179: 2029-2037, 1997. PubMed: 9068651
32528: O'Callaghan RJ, et al. The role of an uncharacterized exoprotein, protease IV, in corneal virulence. Invest. Ophthalmol. Vis. Sci. 37: 534-543, 1996. PubMed: 8595953
90283: CLSI Performance Standards for Antimicrobial Susceptibility Testing; Sixteenth Informational Supplement. Wayne, PA:Clinical and Laboratory Standards Institute;CLSI M100-S17, 2007
92112: API 20 NE. bioMerieux
